Show simple item record

dc.contributor.authorZhang, H. et al.
dc.date.accessioned2020-12-18T23:23:04Z
dc.date.available2020-12-18T23:23:04Z
dc.date.issued2020-03-27
dc.identifier.urihttps://doi.org/10.1111/jdv.16389en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/2434
dc.description.abstractDear Editor, Coronavirus disease, first emerged in Wuhan, China, rapidly spread all over the country since December 2019. Up to now, the epidemic situation in China remains stable, while the global march of the virus is seemingly unstoppable, especially in South Korea, Iran and Italy. Here, we reported what dermatologists could do to cope with novel coronavirus from a Chinese dermatologist’s perspective. Dermatologists in epidemic areas may receive and cure confirmed or suspected patients in dermatological wards. Tao et al. recommended emergency management plans in dermatology departments. Suspected or confirmed novel coronavirus patients should be strictly handled according to rules and regulations on nosocomial infection. Zhang et al. identified self‐reported drug hypersensitivity (11.4%) and urticaria (1.4%) in 140 patients infected by novel coronavirus. Teleconsultation could be provided by dermatologists; if it is not effective, bedside consultation is needed. In outpatient and emergency in the department of dermatology, pre‐examination and triage are needed to differentiate patients with fever. Patients with symptoms of fever, cough and dyspnoea, with or without epidemiological contact history, should be referred to the fever clinic. Dermatologists should participate in the diagnosis and treatment of patients who have fever and rash after pre‐examination and triage. Strict protection to prevent cross‐infection should be re‐emphasized. [...]en_US
dc.languageEnglishen_US
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectCoronavirus Infectionsen_US
dc.subjectInfectious Diseasesen_US
dc.subjectDermatologyen_US
dc.subjectDermatologistsen_US
dc.subjectChinaen_US
dc.titleWhat dermatologists could do to cope with the novel coronavirus (SARS‐CoV‐2): a dermatologist’s perspective from Chinaen_US
eihealth.countryOthersen_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalJournal of the European Academy of Dermatology and Venereologyen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record